Articular cartilage disorder

disease
On this page

Also known as articular cartilage disorder involving ankle and footarticular cartilage disorder involving forearmarticular cartilage disorder involving handarticular cartilage disorder involving multiple sitesarticular cartilage disorder involving pelvic region and thigharticular cartilage disorder involving shoulder regionarticular cartilage disorder involving upper armarticular cartilage disorder of ankle and/or footarticular cartilage disorder of forearmarticular cartilage disorder of handarticular cartilage disorder of multiple sitesarticular cartilage disorder of shoulder regionarticular cartilage disorder of the pelvic region and thigharticular cartilage disorder of upper armarticular cartilage of joint diseasearticular cartilage of joint disease or disorderdisease of articular cartilage of jointdisease or disorder of articular cartilage of jointdisorder of articular cartilage of joint

Summary

Articular cartilage disorder (MONDO:0003816) is a disease with 1 GWAS associations across 8 studies and 4 clinical trials. A subtype of arthropathy — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

  • GWAS associations: 1
  • Clinical trials: 4

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

FieldValue
Canonical namearticular cartilage disorder
Mondo IDMONDO:0003816
DOIDDOID:6227
SNOMED CT53417006
UMLSC0158073
MedGen510440
Anatomy (UBERON)UBERON:0010996
Is cancer (heuristic)no

Also known as: articular cartilage disorder · articular cartilage disorder involving ankle and foot · articular cartilage disorder involving forearm · articular cartilage disorder involving hand · articular cartilage disorder involving multiple sites · articular cartilage disorder involving pelvic region and thigh · articular cartilage disorder involving shoulder region · articular cartilage disorder involving upper arm · articular cartilage disorder of ankle and/or foot · articular cartilage disorder of forearm · articular cartilage disorder of hand · articular cartilage disorder of multiple sites · articular cartilage disorder of shoulder region · articular cartilage disorder of the pelvic region and thigh · articular cartilage disorder of upper arm · articular cartilage of joint disease · articular cartilage of joint disease or disorder · disease of articular cartilage of joint · disease or disorder of articular cartilage of joint · disorder of articular cartilage of joint

Data availability: 1 GWAS association (8 studies).

Disease family

This is a subtype of arthropathy. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › musculoskeletal system disorderskeletal system disorderarthropathyarticular cartilage disorder

Related subtypes (23): transient arthropathy, synovial plica syndrome, hypermobility syndrome, Tietze syndrome, neurogenic arthropathy, Behcet syndrome arthropathy, ankylosis, bursitis, synovium neoplasm, hydrarthrosis, hemarthrosis, tenosynovitis, ganglion or cyst of synovium/tendon/bursa, spondyloarthropathy, temporomandibular joint disorder, arthritic joint disease, de Quervain disease, frozen shoulder, patellofemoral pain syndrome, secondary hypertrophic osteoarthropathy, shoulder impingement syndrome, crystal arthropathy, vertebral joint disorder

Subtypes (1): chondromalacia

Genetics & variants

GWAS landscape

1 GWAS associations across 8 studies. Top hits map to 0 distinct genes (as reported by GWAS).

Top associations by p-value

rsIDp-valueGeneRisk alleleOdds ratio
rs14906267521e-08NA - FAM230C?

Top studies (by case count)

StudyLead authorYearCasesControlsTitle
GCST90080449Backman JD20211,157386,756Exome sequencing and analysis of 454,787 UK Biobank participants.
GCST90084435Backman JD20211,157386,756Exome sequencing and analysis of 454,787 UK Biobank participants.
GCST90080448Backman JD2021605387,325Exome sequencing and analysis of 454,787 UK Biobank participants.
GCST90084434Backman JD2021605387,325Exome sequencing and analysis of 454,787 UK Biobank participants.
GCST90436735Zhou W2018500402,633Efficiently controlling for case-control imbalance and sample relatedness in large-scale genetic association studies.
GCST90044598Jiang L2021484455,864A generalized linear mixed model association tool for biobank-scale data.
GCST90482437Verma A2024419448,990Diversity and scale: Genetic architecture of 2068 traits in the VA Million Veteran Program.
GCST90651502Liu TY2025122235,669Diversity and longitudinal records: Genetic architecture of disease associations and polygenic risk in the Taiwanese Han population.

Variant details and genetic-evidence tiers

Tier distribution (top 50 variants)

TierVariants
Tier 1: coding0
Tier 2: splice/UTR0
Tier 3: regulatory0
Tier 4: intronic/intergenic1

MAF distribution

BucketVariants
common (>=0.05)0
low_freq (0.01-0.05)0
rare (<0.01)0
unknown1

Functional consequences

ConsequenceCount
intergenic_variant1

Top variants

rsIDChrPosAllelesMAFConsequenceGenep-valueTier
rs14906267521316358301G>A,C,Tintergenic_variantNA - FAM230C1e-08Tier 4: intronic/intergenic

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 4.

Phase distribution (across all retrieved trials)

PhaseTrials
Not specified3
PHASE31

Top trials by phase / activity

NCTPhaseStatusTitle
NCT01400607PHASE3TERMINATEDNeocartilage Implant to Treat Cartilage Lesions of the Knee
NCT01410136Not specifiedTERMINATEDChondrofix Osteochondral Allograft Prospective Study
NCT01690689Not specifiedCOMPLETEDInvestigation of a Customized Femoral Resurfacing Implant
NCT05424848Not specifiedCOMPLETEDFemoral Cartilage Thickness in Parkinson’s Disease

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.